Literature DB >> 35464670

Determination of the Estrogen Receptor Status of Leptomeningeal Metastasis in Patients with Metastatic Breast Cancer Using [18F]-FES PET/CT: a Case Report.

Jeongryul Ryu1, Jae Ho Jeong2, Dae Hyuk Moon1, Dong Yun Lee1.   

Abstract

Accurate determination of the hormone receptor status in patients with breast cancer is necessary to provide better palliative treatment because of the frequent discordant status of hormone receptors between primary breast cancer and metastatic lesions. In particular, the invasive nature and small number of cells recovered from the cerebrospinal fluid collected through lumbar puncture limit the detailed immunocytochemistry investigation of leptomeningeal metastasis. Moreover, none of the conventional imaging modalities provide any information on the hormone receptor status of leptomeningeal metastasis in patients with breast cancer. Herein, we report estrogen receptor-positive leptomeningeal metastasis clearly demonstrated by 16α-[18F]-fluoro-17β-estradiol ([18F]-FES) positron emission tomography/computed tomography (PET/CT) in a patient with metastatic breast cancer.
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2022.

Entities:  

Keywords:  16α-[18F]-fluoro-17β-estradiol ([18F]-FES); Breast cancer; Estrogen receptor; Leptomeningeal metastasis

Year:  2022        PMID： 35464670      PMCID： PMC8976712          DOI： 10.1007/s13139-022-00736-8

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


  15 in total

1.  Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study.

Authors:  Sun Young Chae; Sei Hyun Ahn; Sung-Bae Kim; Sangwon Han; Suk Hyun Lee; Seung Jun Oh; Sang Ju Lee; Hee Jeong Kim; Beom Seok Ko; Jong Won Lee; Byung Ho Son; Jisun Kim; Jin-Hee Ahn; Kyung Hae Jung; Jeong Eun Kim; Seog-Young Kim; Woo Jung Choi; Hee Jung Shin; Gyungyub Gong; Hyo Sang Lee; Jung Bok Lee; Dae Hyuk Moon
Journal:  Lancet Oncol       Date:  2019-03-04       Impact factor: 41.316

2.  Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer.

Authors:  Jorianne Boers; Carolina P Schröder; Geke A P Hospers; Erik F J de Vries; Andor W J M Glaudemans
Journal:  Clin Nucl Med       Date:  2020-11-10       Impact factor: 7.794

3.  Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period.

Authors:  Junichiro Watanabe; Koichi Mitsuya; Shogo Nakamoto; Hideyuki Harada; Shoichi Deguchi; Nakamasa Hayashi; Yoko Nakasu
Journal:  Breast Cancer Res Treat       Date:  2021-05-08       Impact factor: 4.872

Review 4.  Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Rupert Bartsch; Anna S Berghoff; Dimosthenis Chrysikos; Evandro de Azambuja; Meletios-Athanassios Dimopoulos; Matthias Preusser
Journal:  Breast Cancer Res Treat       Date:  2013-04-16       Impact factor: 4.872

Review 5.  Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.

Authors:  Clasina M Venema; Giulia Apollonio; Geke A P Hospers; Carolina P Schröder; Rudi A J O Dierckx; Erik F J de Vries; Andor W J M Glaudemans
Journal:  Clin Nucl Med       Date:  2016-11       Impact factor: 7.794

6.  Leptomeningeal metastases in breast cancer.

Authors:  Brian J Scott; Santosh Kesari
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

7.  A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer.

Authors:  Melissa Bear; Sara M Tolaney; Solmaz Sahebjam; Emilie Le Rhun; Thomas Bachelot; Peter Kabos; Ahmad Awada; Denise Yardley; Arlene Chan; Pierfranco Conte; Véronique Diéras; Nancy U Lin; Sonya C Chapman; Zhengyu Yang; Yanyun Chen; Carey K Anders
Journal:  Clin Cancer Res       Date:  2020-07-21       Impact factor: 12.531

8.  Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.

Authors:  Jin Sun Lee; Michelle E Melisko; Mark Jesus M Magbanua; Andrea T Kablanian; Janet H Scott; Hope S Rugo; John W Park
Journal:  Breast Cancer Res Treat       Date:  2015-10-31       Impact factor: 4.872

9.  Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden.

Authors:  G Frisk; T Svensson; L M Bäcklund; E Lidbrink; P Blomqvist; K E Smedby
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

10.  Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images.

Authors:  Bomi Gil; Eo-Jin Hwang; Song Lee; Jinhee Jang; Hyun Seok Choi; So-Lyung Jung; Kook-Jin Ahn; Bum-Soo Kim
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.